
deniz balci
@dbalci
Hepatopancreatobiliary & Transplant Surgeon @ Bahçeşehir University School of Medicine Medical Park Göztepe Hospital, Istanbul.
ID: 91654480
http://Www.denizbalci.com.tr 21-11-2009 21:11:21
629 Tweet
1,1K Takipçi
988 Takip Edilen

Amazing 4 days, first presenting our experience at German Society of Surgery meeting followed up with Korean HPB 2025 meeting. We shared the latest advances & Cutting edge surgery with global experts. Thanks DCK and Korean HPB surgery society for the kind invitation Bahçeşehir Uni (BAU)





#ISLS2025 SESSION HIGHLIGHTS Don't miss Session 3 on #LiverTransplantation with Yee Lee Cheah, Ki-Hun Kim, Dieter Broering, Gyu-Seog Choi. Moderated by deniz balci and Gonzalo Sapisochin Visit our website for the Preliminary Program #MedicalConference #RoboticSurgery


It was an honor to contribute to the ILTS 2025, Singapore, I had the privilege of delivering 1Advanced Two-Stage HPBSurgeries for Biliary Cancers” –2Advanced Two-Stage Liver Transplant Techniques to Enhance Donor Safety and Expand the Donor Pool. Thanks Nazia Selzner Alfred Kow




⚠️Risk factors for pancreatic cancer eClinicalMedicine – The Lancet Discovery Science ➡️Umbrella review 🚨New risk factors: ✔️autoimmune liver disease ✔️BRCA gene mutation ✔️co-infection with hepatitis B and C ✔️insulin use 👉thelancet.com/journals/eclin… OncoAlert #cancer #oncology #MedX


Please check the messages for a timely discussion on this topic, we need to go deeper on this... Shimul A. Shah IHPBA ISLSCongress Karim J Halazun MD Umberto Cillo


🧬Postop ctDNA after resection of HCC JCO Precision Oncology 🚨MRD positivity: 29.4% (all recurred) HR: 7.20 [95% CI, 2.6 to 20.0]; P < .0001 🚨In the surveillance window: 32.3% positive (all recurred) HR: 18.00 [95% CI, 3.9 to 85.0]; P < .0001 👉ascopubs.org/doi/10.1200/PO… #cancer
![Erman Akkus (@erman_akkus) on Twitter photo 🧬Postop ctDNA after resection of HCC
<a href="/JCOPO_ASCO/">JCO Precision Oncology</a>
🚨MRD positivity: 29.4% (all recurred)
HR: 7.20 [95% CI, 2.6 to 20.0]; P < .0001
🚨In the surveillance window: 32.3% positive (all recurred)
HR: 18.00 [95% CI, 3.9 to 85.0]; P < .0001
👉ascopubs.org/doi/10.1200/PO…
#cancer 🧬Postop ctDNA after resection of HCC
<a href="/JCOPO_ASCO/">JCO Precision Oncology</a>
🚨MRD positivity: 29.4% (all recurred)
HR: 7.20 [95% CI, 2.6 to 20.0]; P < .0001
🚨In the surveillance window: 32.3% positive (all recurred)
HR: 18.00 [95% CI, 3.9 to 85.0]; P < .0001
👉ascopubs.org/doi/10.1200/PO…
#cancer](https://pbs.twimg.com/media/Gvb_LfRXQAAjrla.jpg)


